SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (285)9/21/1997 1:28:00 AM
From: Bharat H. Barai   of 442
 
Dear Andrew,

I have not talked to Somatogen since my last posting.

I have no good explanation for drop in SMTG. As I have mentioned before, I am baffled by low price of this stock. SMTG has one of revolutionary products and yet it trades so low. I guess it is beyond my competence to understand the market dynamics. I have felt several times in past about many stocks that trade at irrational prices, either extreme low or extreme high. I suppose you need support of big brothers of wall street. Somatogen will have to get a partner and come close to getting FDA approval before there will be meaningful increase in the stock prices. May be Somatogen management needs to do better job of PR with Wall Street.

B.H. Barai MD
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext